This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Piper Sandler Adjusts Price Target on Perrigo to $36 From $39, Maintains Overweight Rating MT
Transcript : Perrigo Company plc Presents at Oppenheimer's 24th Annual Virtual Consumer Growth and E-Commerce Conference, Jun-11-2024 01:30 PM
Perrigo Company plc Appoints Todd Penegor as Member of Board and to Serve on Audit Committee, Effective June 21, 2024 CI
Perrigo Company plc Announces Executive Changes CI
Perrigo's Q1 Adjusted Earnings, Net Sales Drop MT
Transcript : Perrigo Company plc, Q1 2024 Earnings Call, May 07, 2024
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 Revenue $1.08B MT
Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 EPS $0.29, vs. Street Est of $0.23 MT
Perrigo Company plc Reports Earnings Results for the First Quarter Ended March 30, 2024 CI
Perrigo Company plc Reaffirms Earnings Guidance Year 2024 and Provides Sales Guidance for the Second Half of 2024 CI
Perrigo Announces Executive Transition for Its Consumer Self-Care International Business CI
Perrigo Keeps Quarterly Dividend at $0.276 Per Share; Payable June 18 to Shareholders on May 31 MT
Perrigo Company plc Announces Quarterly Dividend, Payable on June 18, 2024 CI
Sector Update: Health Care Stocks Decline Late Afternoon MT
Perrigo Receives Binding Offer to Sell HRA Pharma Rare Diseases Business for Up to $295 Million MT
Esteve Healthcare S.L. signed a binding offer to acquire HRA Pharma Rare Diseases America, LLC from Perrigo Company plc for approximately ?280 million. CI
Piper Sandler Raises Perrigo's Price Target to $39 From $35, Maintains Overweight Rating MT
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors RE
Multiple CVS Caremark Plans to Cover Perrigo's Opill at No Cost MT
Multiple CVS Caremark Plans Reportedly to Cover Perrigo's Opill at No Cost MT
Sector Update: Health Care Stocks Rise Late Afternoon MT
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading MT
Perrigo Shares Rise After Wisconsin Governor Makes Birth Control Pill Free for Medicaid Members MT
Transcript : Perrigo Company plc Presents at UBS Global Consumer and Retail Conference 2024, Mar-13-2024 04:00 PM
Perrigo Company plc Announces Erica L. Mann Not to Stand for Re-Election to its Board of Directors CI
Chart Perrigo Company plc
More charts
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract manufacturing) in the United States and Canada, including the HRA Pharma self-care business (Women's Health and Skin-Care categories) in the United States and Canada. The CSCI segment comprises its consumer self-care business in Europe and Australia, which are primarily branded, its store brand business in the United Kingdom and parts of Europe and Asia and includes the HRA Pharma self-care business (Women's Health, Skin-Care and Rare-Disease categories) in Europe. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, Nutrition and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
25.78 USD
Average target price
38.75 USD
Spread / Average Target
+50.31%
Consensus
  1. Stock Market
  2. Equities
  3. PRGO Stock
  4. News Perrigo Company plc
  5. Earnings Flash (PRGO) PERRIGO COMPANY Posts Q1 Revenue $1.08B